厦门市领导机关内宾接待工作暂行规定
作者:法律资料网 时间:2024-07-12 15:16:26 浏览:8655
来源:法律资料网
下载地址: 点击此处下载
厦门市领导机关内宾接待工作暂行规定
厦门市领导机关内宾接待工作暂行规定
中共厦门市委办公厅 厦门市人民
一、总则
第一条 为使厦门市党政机关接待工作程序化、规范化，发挥接待工作为改革开放和特区两个文明建设服务的作用，特制定本规定。
第二条 市接待办是主管接待工作的职能部门。在市委、市政府领导下，具体负责接待对象的食宿行安排，协调我市内宾接待工作；协助市委办、市人大办、市政府办、市政协办、市纪委办做好党和国家领导人，省、地级领导及其随员的接待工作，并对市属各部、委、办、局内宾接待
工作担负联络、组织、协调、检查和监督的职责。
第三条 内宾接待对象主要是指地、市以上领导和机关及其所率的检查、参观、考察团组。
第四条 承担接待的单位应制定接待方案，认真组织、精心安排好座谈、参观、考察和迎送工作，并派员陪同。
第五条 市接待办每日需将到达我市的副地（厅）级以上客人名单综合上报市委、市政府办公厅。
第六条 接待工作要贯彻中央和国务院的精神，力求热情服务、简化礼仪、轻车简从、节俭得体和安全周到。
二、任务分工
第七条 市委办公厅负责接待中共中央政治局候补委员以上领导、中共中央办公厅及直属单位、各省、市、自治区党委（含办公厅）领导及其所率团组。
第八条 市人大办公厅负责接待全国人大常委会领导、常委会委员和各专门委员会领导，各省、市、自治区、地（市）级人大机关领导及其所率团组。
第九条 市政府办公厅负责接待国务院领导、国务院办公厅及直属单位和各省、市、自治区政府（含办公厅）领导同志及其所率团组。
第十条 市政协办公厅负责接待全国政协领导、政协常委和各专门委员会领导及省、市、自治、地（市）级政协机关领导及其所率团组。
第十一条 市纪委办公厅负责接待中纪委、监察部领导及所属机关和省、市、自治区纪委、监察机关领导及各地（市）级纪委、监察机关领导及其所率团组。
第十二条 身兼数职的中央领导，按其所担任的主要职务，由市委办公厅牵头协调有关部门接待。
第十三条 中央军委、各总部领导，最高人民法院院长、最高人民检察院检察长，由市委、市政府办公厅及市接待办协调有关机关、单位对口接待。
第十四条 退居二线的党和国家领导人，按离退休前所担任职务，由对口单位接待。省部级离退休老干部按上述原则对口安排接待。
第十五条 中央、国务院以及省、市、自治区的部、委办、局领导，由本市相关部门对口负责接待。
第十六条 地、市党政领导同志及其所率团组，由市接待办负责接待，相关部门协助。
第十七条 在我市召开的全国、全省性会议由会议主办单位负责接待，市接待办配合。
第十八条 根据临时任务的需要，市领导可指定有关部门和单位负责接待有关方面的客人。
三、迎送、陪同
第十九条 党和国家领导人及省、市、自治区党委、人大、政府、政协、纪委的领导抵离厦，分别由市委、市人大、市政府、市政协、市纪委秘书长、副秘书长或办公厅副主任到车站、机场、码头或交界处迎送，相关市领导在下榻处迎送和陪同视察工作。
第二十条 中央、国务院部、委、办、局领导，省、市、自治区党委、政府部门领导抵离厦，由党委、政府的相关部门领导迎送和陪同。
第二十一条 全国和各省、市、自治区人大、政协各专门委员会领导抵离厦、由人大、政协办公厅协调相关部门领导负责迎送、陪同。
第二十二条 地市党委、政府领导抵离厦，由市接待办负责迎送和陪同，并负责协调相关部门领导陪同。
第二十三条 知名人士、专家学者的接待，根据实际情况由市领导确定相关部门负责迎送和陪同。
四、会见、陪餐
第二十四条 客人需市领导会见应由接待单位分别报市委、市人大、市政府、市政协、市纪委办公厅审批，由办公厅安排相关领导出席。各有关领导应按时间、地点准时到场，接待人员应做好各项准备工作。
第二十五条 一批客人一般只安排领导陪餐一次。涉及几个部门和单位共同接待的，应由主要负责接待的单位牵头组织。
第二十六条 控制陪餐人数。接待单位应将接待对象和陪餐人数报市接待办安排，其他人员可安排工作餐。
五、食宿、交通
第二十七条 接待内宾一般安排在市接待办所属宾馆，按规定标准安排食宿。特殊情况需要安排在其他宾馆、酒店食宿，必须报领导同意后，由市接待办统一安排。
第二十八条 接待对象的住宿、就餐标准由市接待办按规定标准统一下达通知。
第二十九条 党和国家领导人以及各省、市、自治区领导的接待用车，统一由市接待办提供保障。市委、市政府办公厅接待客人用车由市接待办负责提供。市人大、市政协、市纪委办公厅的接待用车按接待任务分工负责提供车辆，有困难商请市接待办统筹解决。其他部门接待的客人，
由各部门自行解决交通工具。除省、部级以上领导可跨市用车外，其他客人的接待用车一般不派出市外。
第三十条 省、部级以上领导因活动需要，可使用“鹭江”号游艇。
六、经费开支
第三十一条 内宾接待对象，其住宿、就餐、用车、就医等经费开支，严格按照市委办发[1996]041号文通知规定的要求执行。
第三十二条 各种会议和实行经费包干的部门、单位，需要请市领导出面会见、陪餐等接待经费，原则上由各主办单位负责。
第三十三条 市直各部门、单位对口接待的客人，需要市接待办协助安排食宿者，费用自理。
第三十四条 各省、地（市）来厦举办经贸洽谈会、恳谈会及新闻发布会等招商活动，或本市和驻厦各部门、单位邀请来厦参加其组织活动的客人（含考察的团组），接待经费由主办单位负责。
七、安全、警卫
第三十五条 党和国家领导人的安全、警卫，按照中央有关规定执行。
第三十六条 中央和国家机关各部部长和相当于部长的领导，各兄弟省、市、自治区党政主要领导或重要任务，经市领导同意，由办公厅下达警卫、警车疏导任务。
本规定从文件下达即日起执行。
1998年7月3日
下载地址: 点击此处下载
新疆维吾尔自治区实施《中华人民共和国工会法》办法
新疆维吾尔自治区实施《中华人民共和国工会法》办法
新疆维吾尔自治区人大常委会
（1994年9月24日新疆维吾尔自治区第八届人民代表大会常务委员会第十次会议通过）
第一条 为了贯彻实施《中华人民共和国工会法》（以下简称《工会法》），结合自治区实际，制定本办法。
第二条 工会各级组织依照《工会法》和《中国工会章程》独立自主地开展工作，依法行使权利和履行义务。
地方各级国家机关及所属部门、企业、事业单位应当支持工会依法开展工作。任何单位和个人不得侵犯工会的合法权益。
第三条 工会各级组织对各民族职工进行爱国主义、集体主义、社会主义教育，民主、法制、纪律教育，以及民族政策和马克思主义民族观教育。
工会各级组织动员和教育各民族职工积极参加建设和改革，正确处理国家、集体、个人三者利益的关系，努力完成生产和工作任务。
第四条 工会各级组织必须保持同各民族职工群众的密切联系，听取和反映职工的意见和要求。参与协调劳动关系，调节社会矛盾，促进社会稳定和经济发展。
第五条 自治区总工会依照国家有关规定加强和发展同国外工会组织之间的友好合作关系。
第六条 县级以上地方建立地方各级总工会。地方总工会是当地地方工会组织和产业工会地方组织的领导机关。
自治区总工会在地区设立办事处，设区的市总工会在区建立区一级工会组织，乡（镇）、城市街道建立乡（镇）和街道工会组织。
第七条 凡在自治区境内的企业、事业单位和机关应当依法组建工会。
外商投资企业，具备条件的乡镇企业、私营企业应当在开业或投产六个月内组建工会。
上级工会组织应当督促、指导并帮助下级单位组建工会，有关单位应当支持和帮助。
第八条 成立或撤销、合并工会组织，必须经会员大会或会员代表大会通过，并报上一级工会批准。工会基层组织所在的企业终止，或所在的事业单位、机关被撤销，该工会组织相应撤销，并报上级工会备案。其他组织和个人不得阻碍职工依法组织和参加工会，不得随意撤销、合并工
会组织，也不得把工会组织的机构归属其他工作部门。
第九条 各级工会设女职工委员会，女职工不足二十五人的基层工会设女职工委员，依法维护女职工的合法权益，保护女职工的特殊利益。
第十条 县级以上各级总工会、产业工会可以建立法律咨询工作机构或者配备专职人员，为职工和所属工会提供法律服务。
第十一条 工会主席、副主席依照《中国工会章程》规定民主选举产生，并报上一级工会批准。工会主席、副主席实行任期制。
第十二条 企业、事业单位和机关应当根据国家有关规定配备专、兼职工会工作人员，保障工会开展工作。
工会应当加强对工会工作人员的培养，重视培养和使用少数民族工会工作人员。
第十三条 工会应当代表和组织职工对企业、事业单位遵守劳动法律、法规的情况进行民主监督。对企业、事业单位违反劳动法律、法规或者劳动合同，侵犯职工合法权益的行为，有权要求企业、事业单位或者有关部门纠正和处理。
第十四条 工会与企业、事业单位建立协商制度，协商解决涉及职工切身利益的问题。帮助和指导职工与企业、事业单位行政方面签订劳动合同，可以代表职工与企业、事业单位行政方面就劳动报酬、工作时间、休息休假、劳动安全卫生、保险福利等事项签订集体合同或其他协议，并
监督双方认真履行。
第十五条 工会参与劳动争议的调解、仲裁工作。
用人单位设立的劳动争议调解委员会主任由工会代表担任。
县级以上地方设立的劳动争议仲裁委员会，应当有同级工会代表参加。工会兼职劳动争议仲裁员经同级劳动争议仲裁委员会聘任后，依法参加仲裁活动。
第十六条 工会发现企业的劳动条件和安全卫生设施不符合国家规定的标准，有权进行调查，提出意见，有关部门应当认真处理。
第十七条 企业行政方面强令工人违章冒险作业，发生重大伤亡事故，造成严重后果的，工会有权要求对责任人员依法追究刑事责任。
第十八条 工会监督企业、事业单位和机关，定期对作业环境和职工健康状况、职业病防治工作进行检测和检查。
工会监督企业、事业单位劳动保护措施的落实和劳动保护经费的提取与使用。
第十九条 工会应当依法维护职工的合法权益，重视维护少数民族职工和女职工的劳动权益。
工会应当协助企业、事业单位加强对少数民族职工和女职工进行科学、文化、技术、业务培训，提高他们的科学、文化、技术、业务素质，大量培养各种科学技术、经营管理等专业人才和技术工人。
第二十条 县级以上人民政府与同级工会、政府所属部门与相应同级产业工会应当建立联席会议制度。每年至少召开一次联席会议，通报政府及有关部门的重要工作部署和相关的行政措施，研究解决工会反映的职工的意见、要求和问题。
第二十一条 企业、事业单位发生停工怠工事件，工会应当会同主管部门或者有关方面积极做好疏导工作，协商解决职工提出的可以解决的合理要求，协助企业、事业单位尽快恢复正常生产（工作）秩序。
第二十二条 工会组织职工开展社会主义劳动竞赛、合理化建议、技术革新和技术协作活动，总结推广先进经验。
企业、事业单位应当按照国家有关规定提取劳动竞赛奖励经费。劳动竞赛奖励经费用于工会组织职工开展社会主义劳动竞赛活动。
工会会同有关部门和企业、事业单位做好先进生产（工作）者和劳动模范的评选、表彰、培养和管理工作。
第二十三条 工会应当鼓励支持职工学习文化科学技术和管理知识，开展健康的文化体育活动，办好工会文化、教育、体育事业。
第二十四条 工会应当支持企业的生产和经营管理，教育职工遵守劳动纪律和规章制度，调动职工的积极性，努力完成各项任务，提高经济效益，促进企业发展。
第二十五条 工会协助和督促企业、事业单位做好劳动保险、劳动保护工作，办好职工集体福利事业，改善职工生活。
第二十六条 工会应当听取和反映离休、退休职工的意见和要求，关心离休、退休职工的生活。
第二十七条 工会工作人员应当依法履行职责，如实反映职工的意见和要求，自觉接受职工群众的监督，全心全意为职工服务。
第二十八条 国有企业应当依法建立健全职工（代表）大会制度，保障职工依法行使民主管理权利。工会委员会负责职工代表大会的日常工作，检查、督促职工（代表）大会决议的执行。
职工（代表）大会至少每半年召开一次。闭会期间需要临时解决的重要问题，由企业的工会委员会召集职工代表团（组）长和专门委员会（小组）负责人联席会议协商解决，并向下一次职工（代表）大会报告，予以确认。
国有企业的管理委员会应有工会主席、职工代表和女职工委员会的代表参加，人数不得少于管理委员会全体成员的三分之一。
第二十九条 集体企业的工会委员会是职工（代表）大会的工作机构，组织职工参加民主管理和民主监督，依法维护职工的合法权益。
第三十条 中外合资经营企业、中外合作经营企业的工会组织，依法维护职工的合法权益。企业研究决定有关职工的工资福利、安全生产以及劳动保护、劳动保险等涉及职工切身利益的问题时，应当通知工会代表列席会议，听取工会的意见和建议，取得工会的合作。
外商独资企业和私营企业工会与企业建立协商谈判制度，实行民主参与，依法代表和维护职工的政治权利和物质利益，维护国家和社会利益，尊重投资者的合法权益，共谋企业发展。
第三十一条 国有资产占控股地位的股份制企业，依照宪法和有关法律规定，通过职工（代表）大会和其他形式，实行民主管理。企业研究决定有关职工工资、福利、安全生产以及劳动保护、劳动保险等涉及职工切身利益的问题，应当事先听取企业工会和职工的意见，并邀请工会或者
职工代表列席有关会议。
依照《中华人民共和国公司法》的规定，应参加企业董事会和监事会的职工代表，由工会组织职工民主选举产生。
第三十二条 机关工会委员会是职工（代表）大会的工作机构，负责职工（代表）大会的日常工作。机关工会应协助行政领导加强民主建设，参加干部民主评议，关心职工生活，反映职工的意见和要求。
第三十三条 建立工会组织的企业、事业单位和机关，应当按照每月全部职工工资总额的百分之二定期向工会拨交当月的工会经费。全部职工工资总额的组成按国家统计局的统一规定计算。
由财政拨款的机关、事业单位，已建立工会组织的，应把按职工工资总额的百分之二拨交工会经费列入年度预算。
对逾期未交或少拨交工会经费的单位，工会应及时催交；经多次催交仍不拨交的，工会可按照国家有关规定处理。
第三十四条 工会组织合并，其经费、财产归合并后的工会所有；工会组织依法撤销，其经费、财产由上级工会按照有关规定妥善处理。
第三十五条 凡违反《工会法》和本办法的规定，阻碍职工组织和参加工会，随意撤销、合并工会组织，侵占工会财产，挪用、贪污工会经费以及对工会工作者依法行使职权进行打击报复的，由主管部门或者政府有关部门视其情节轻重予以处理；构成犯罪的，由司法机关依法追究刑事
责任。
第三十六条 工会工作人员违反《工会法》和本办法的规定，不履行职责的，由所在工会或上级工会批评教育，直至建议原选举单位予以罢免。给职工、工会或者国家造成损失的，给予行政处分；构成犯罪的，由司法机关依法追究刑事责任。
第三十七条 本办法自公布之日起施行。
1994年9月24日
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
(SFDA Decree No. 25)
The Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim), adopted by the State Food and Drug Administration, the General Administration of Customs of the People’s Republic of China and the General Administration of Sport of China, is hereby promulgated in the decree sequence number of the State Food and Drug Administration and shall come into force as of September 1, 2006.
Shao Mingli
Commissioner
State Food and Drug Administration
Mou Xinsheng
Minister
General Administration of Customs of the People’s Republic of China
Liu Peng
Minister
General Administration of Sport of China
July 28, 2006
Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)
Article 1 The Provisions are formulated with a view to standardizing the administration of import and export of anabolic agents and peptide hormones in accordance with the Drug Administration Law of the People’s Republic of China, Customs Law of People's Republic of China, Anti-doping Regulations and other relevant laws and administrative regulations.
Article 2 The State adopts license control on the import and export of anabolic agents and peptide hormones.
Article 3 The importer shall apply for the importation of anabolic agents and peptide hormones to the State Food and Drug Administration.
Article 4 For the importation of anabolic agents and peptide hormones for medical purpose, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Copy of the Import Drug License (or the Pharmaceutical Product License) (original or duplicate);
(4) Copy of the Drug Supply Certificate, Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importer; to import drug substance and intermediate preparations including preparations to be repackaged in China for their own needs, drug manufacturers shall submit copies of the Drug Manufacturing Certificate, Corporate Business License and Organization Code Certificate;
(5) Where holders of the Import Drug License (or the Pharmaceutical Product License) entrust other companies to export their drugs, they shall provide the authorization letter for export.
All copies mentioned above should be stamped with the official seal of the importer.
Article 5 For the importation of anabolic agents and peptide hormones for teaching and scientific research purposes, the importers shall submit the following materials:
(1) Application Form for Drug Import;
(2) Copy of the purchasing contract or order form;
(3) Certificates of legitimate qualifications of users in China, calculation basis for the quantity of the drug in use and letter of guarantee issued by the user for legitimate use and management of the drug;
(4) Approval documents for relevant scientific research projects or approval documents of relevant competent authority;
(5) Where entrusted by users for importation, importers shall provide copies of the authorization agreement, the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the importers.
All copies mentioned above should be stamped with the official seal of the importer.
Article 6 Where a enterprise in China entrusted by an overseas enterprise for contract manufacturing needs to import anabolic agents and peptide hormones, it shall provide materials required in Items (1), (3) and (5) of Paragraph 1 of Article 5, in addition, official documents to prove recorded by the local (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government.
All copies mentioned above should be stamped with the official seal of the importer.
Article 7 The State Food and Drug Administration shall decide whether or not to approve the import within 15 working days after receiving the application for import and the relevant materials. Where the application is approved, the State Food and Drug Administration shall issue the Import License for the drug; where the application is not approved, the State Food and Drug Administration shall give reasons in writing.
Article 8 The importer may declare to the customs of the ports where drug importation is permitted upon presenting the Import License for the drug issued by the State Food and Drug Administration. The customs shall clear the drug in the presence of the Import License for the drug.
The Drug Import Note is not required for import of anabolic agents and peptide hormones.
Article 9 To import anabolic agents and peptide hormones including those sold in China for the first time for medical purpose, the importer shall fill in the Import Drug Clearance Form timely after going through the import formalities and submit the following materials in duplicate to the (food and) drug regulatory department where the port of entry is located, upon presenting the original Import Drug License (or the Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug, to apply for the Notice of Import Drug Port Test:
(1) Copies of the Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the Import License for the drug;
(2) Copies of the Drug Manufacturing Certificate or Drug Supply Certificate, and Copy of the Business License for Enterprises as a Legal Person.
(3) Copy of the certificate of origin;
(4) Copy of the purchasing contract;
(5) Copies of packing list, bill of lading and freight invoice;
(6) Copy of the certificate of analysis;
(7) Format of drug insert sheet, package and label (except for drug substance and intermediate preparation);
All copies mentioned above should be stamped with the official seal of the importer.
Article 10 After checking the received Import Drug Clearance Form and relevant materials, the port (food and) drug regulatory department shall return the original Import Drug License (or Pharmaceutical Product License) (original or duplicate) and the original Import License for the drug to the importer, and send the Notice of Import Drug Port Test, along with a copy of the dossier as prescribed in Article 9 of the Provisions, to the port drug testing institute on the same day.
After receiving the Notice of Import Drug Port Test, the port drug testing institute shall contact the importer within two working days and conduct sampling on the storage site. Upon the completion of the sampling, the mark “sampled” shall be stamped on the back of the first page of the original Import License for the drug, with the seal of sampling institute affixed.
Article 11 Anabolic agents and peptide hormones imported for teaching and research purposes or for the domestic manufacturing contracted by overseas enterprises are exempted from testing.
Article 12 The port (food and) drug regulatory department shall report timely to the State Food and Drug Administration in any of the following circumstances:
(1) The port (food and) drug regulatory department refuses to issue the Notice of Import Drug Port Test in accordance with the provisions in Article 17 of the Provisions for Import Drug (Decree No. 4 of the State Food and Drug Administration and the General Administration of Customs);
(2) The port (food and) drug testing institute refuses the sampling in accordance with the requirements in Article 25 of the Provisions for Import Drug.
The port (food and) drug regulatory department shall take mandatory administrative measures to seal up or seize all the imported drugs within the situations prescribed in the previous paragraph. It shall make the decision of allowing shipping back within seven days from the date of the seal-up or seizure, and inform the importer of applying for the Export License for the drug according to the export procedures for anabolic agents and peptide hormones prescribed in the Provisions and return all the import drugs to the original exporting country.
Where the importer fails to respond or make clear its intention to ship back the drugs within ten days after being informed of the decision, the sealed up or seized drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.
Article 13 For imported anabolic agents and peptide hormones out of specifications upon testing by the port drug testing institute, the importer shall provide a detailed report about the distribution and use of all the imported drugs to the port (food and) drug regulatory department where the importer is located within two days after receiving the Import Drug Test Report.
After receiving the Import Drug Test Report, the port (food and) drug regulatory departments shall take mandatory administrative measures to timely seal up or seize all the drugs and, within seven days, decide whether or not to place the case on file.
Where the importer fails to apply for a retesting within the specified timeline or the result of the retesting is still out of specifications, the port (food and) drug regulatory department shall make the decision of allowing shipping back and notify the importer to apply for the Export License for the drug according to export procedures for anabolic agents and peptide hormones prescribed in the Provisions to return all the imported drugs to the original exporting country. Where the importer fails to respond or make clear its intention to ship back the drugs within ten days from the date of receiving the decision, the drugs shall be destroyed under the supervision of the port (food and) drug regulatory department.
Where the result of retesting is in compliance with the specifications, the port (food and) drug regulatory department shall remove the mandatory administrative measures of seal-up and seizure.
The port (food and) drug regulatory department shall handle the case according to the provisions in Paragraph 2, Paragraph 3 and Paragraph 4 of this Article and report the result to the State Food and Drug Administration, and, at the same time, notify the (food and) drug regulatory departments of provinces, autonomous regions and municipalities directly under the Central Government as well as other port (food and) drug regulatory departments.
Article 14 Where domestic drug manufacturers, distributors and medical institutions purchase imported anabolic agents and peptide hormones, the supplier shall provide copies of the Import Drug License (or Pharmaceutical Product License), the Import License for the drug and the Import Drug Test Report, and affix its official seal to the abovementioned copies.
Article 15 The exporter shall apply for exportation of anabolic agents and peptide hormones to the (food and) drug regulatory department of the province, autonomous region or municipality directly under the Central Government, where it is located, and submit the following materials:
(1) Application Form for Drug Export;
(2) Original import permit (or its copy with notarization) provided by the drug regulatory authority of the importing country or region.
If the importing country or region has no license system in the importation of anabolic agents and peptide hormones, the exporter shall provide the official document (original) of the drug regulatory authority of the importing country or region to prove that the import of the drugs of this type is exempted from the import permit, along with one of the following documents:
a. Original official document (or its copy with notarization) granting import provided by the drug regulatory authority of the importing country or region;
b. Certificates of legitimate qualifications of importers and original supporting document (or its copy with notarization) proving legitimate use of the drug;
(3) Copy of the purchasing contract or order form (except for manufacturers that export their own products);
(4) Copy of the export contract or order form;
(5) Where the export drug is an approved one produced by a domestic manufacturer, the Drug Manufacturing Certificate and Business License for Enterprises as a Legal Person of the manufacturer and a copy of the approval document of the drug shall be provided;
Where the export drug is produced by a domestic enterprise under contract of an overseas enterprise, the exporter shall provide a copy of the official document to prove recorded by the local (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government.
(6) Copies of the Business License for Enterprises as a Legal Person, Qualification Certificate for Import and Export Enterprise (or Foreign Trade Operator Filing and Registration Form) and Organization Code Certificate of the exporter.
All copies mentioned above should be stamped with the official seal of the exporter.
Article 16 Where the drugs are to be shipped back in accordance with the requirements in Article 12 and Article 13 of the Provisions, the exporter shall provide the following materials to apply for the Export License for the drug:
(1) Documents proving the request for return of goods made by the original exporter of the exporting country;
(2) Import License for the drug.
Article 17 The (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government shall decide whether or not to approve the export within 15 working days after receiving the export application and relevant materials.
Where the application is approved, the regulatory department shall issue the Export License for the drug; where the application is not approved, the regulatory department shall give reasons in writing.
Where the Export License for the drug is applied for in accordance with the requirements in Article 16 of the Provisions, the issuing authority shall mark “return of the original goods” on the Export License for the drug.
Article 18 The exporter may go through the customs formalities upon presenting the Export License for the drug issued by the (food and) drug regulatory department of the province, autonomous region and municipality directly under the Central Government. The customs shall clear the drug in the presence of the Export License for the drug.
Article 19 The importer and exporter shall provide one more sheet of customs declaration form and apply for sign-back of the sheet when going through the customs formalities. The customs shall stamp the “proof seal” on the sheet in the presence of the Import License for the drug and Export License for the drug. The customs shall charge the cost according to the relevant regulations for issuing certificates.
The importer and exporter shall return the first sheet of the Import License for the drug or Export License for the drug along with the customs declaration form with the seal of the customs, to the issuing regulatory department within one month after completing the import and export.
Where the importer or exporter conducts no relevant importation or exportation after obtaining the Import License for the drug and Export License for the drug, the importer or exporter shall return the original license to the issuing regulatory department within one month after expiration of the license.
Article 20 The validation of the Import License for the drug is one year; the validation of the Export License for the drug is no more than three months (valid within the calendar year).
“One license for one customs clearance” is implemented for the Import License for the drug and Export License for the drug. The license shall be used only once within the validation and its content shall not be altered. Where the import or export is postponed for some reasons, the importer or exporter may request for a new license once with the original one.
Article 21 Where the Import License for the drug or Export License for the drug is lost, the importer or exporter shall report the loss to the original issuing authority in writing immediately. After receiving the loss report, the original issuing authority shall notify the port customs and reissue the license if no harmful consequences are found through confirmation.
Article 22 The Import License for the drug and Export License for the drug are uniformly printed by the State Food and Drug Administration.
Article 23 Where anabolic agents and peptide hormones are imported or exported in the form of processing trade, the customs shall go through and supervise the clearance formalities upon presentation of the Import License for the drug or Export License for the drug. Those not exported for special reasons shall be transferred to and handled by the local (food and) drug regulatory department in accordance with relevant regulations, and the customs shall conduct the verification and cancellation procedures in the presence of relevant documents.
Article 24 Anabolic agents and peptide hormones entering or leaving between bonded zones, export processing zones, other special Customs controlling areas, Customs bonded and controlling areas, with overseas, or between the special Customs controlling areas and the Customs bonded and controlling areas are exempt from application for the Import License for the drug or Export License for the drug, and supervised by the Customs.
Import License for the drug shall be applied for anabolic agents and peptide hormones entering from bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas into other places in China.
Export License for the drug shall be applied for anabolic agents and peptide hormones entering bonded zones, export processing zones, other special Customs controlling areas and Customs bonded and controlling areas from other places of China.
Article 25 Where an individual carries or mails anabolic agents and peptide hormones, within a reasonable amount, into or out of China for medical needs, the customs shall clear the drugs in the presence of prescriptions of medical institutions in accordance with relevant regulations on prescriptions of the competent health department.
Article 26 Besides prescribed in the Provisions, the importation, port test, supervision and control of anabolic agents and peptide hormones for medical purpose are implemented with reference to requirements related to drug importation in the Provisions for Drug Importation.
Article 27 Anabolic agents and peptide hormones imported for medical purpose mentioned in the Provisions refer to the import anabolic agents and peptide hormones to be used for preparation production or to be marketed in China.
Importer refers to the importer specified on the Import License for the drug obtained in accordance with the Provisions.
Exporter refers to the exporter specified on the Export License for the drug obtained in accordance with the Provisions.
Article 28 These Provisions shall go into effect as of September 1, 2006. The Notice on Import and Export of Anabolic Agents and Peptide Hormones (Guo Shi Yao Jian An [2004] No. 474) issued by the State Food and Drug Administration on September 30, 2004 shall be annulled therefrom.
